pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLCpulmo-3818Research ArticleМАКСАВИН (ЛОМЕФЛОКСАЦИН) — МЕЖДУНАРОДНЫЙ ОПЫТ ЭКСПЕРИМЕНТАЛЬНОГО И КЛИНИЧЕСКОГО ИЗУЧЕНИЯ; МАТЕРИАЛ ПОДГОТОВЛЕН СПЕЦИАЛИСТАМИ ФИРМЫ “SEARIE”MAXAGUIN (LOMEFLOXACN): INTERNATIONAL EXPEIENCE OF EXPERIMENTAL AND CLINICAL STUDIES/ THE MATERIALS PROVIDED BY SEARLE’S SPECIALISTSМаксаквип при лечении обострений хронического бронхитаUse of Maxaquin in treatment of exacerbations of chronic bronchitisРедакционнаяСтатьяEditorialArticle19932704202200Приложение2125Copyright © Редакционная С., 20222022Редакционная С.Editorial A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/3818
.
.
ReferencesСтруктура и антибактериальная активность Максаквина / / Пульмонология.— 1993.— Приложепие1.Структура и антибактериальная активность Максаквина / / Пульмонология.— 1993.— Приложепие1.Фармакологические свойства Максаквина / / Там же.Фармакологические свойства Максаквина / / Там же.Wadworth A .N ., Goa K.L. Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use / / Drugs.— 1991.— V ol.42.— P .1018— 1060.Wadworth A .N ., Goa K.L. Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use / / Drugs.— 1991.— V ol.42.— P .1018— 1060.Grassi C., Albera C., P ozzi E. Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronhitis: an Italian multicenter study / / Am. J. Med.— 1992.— Vol.92, Suppl. 4A.— P.103S— 107S.Grassi C., Albera C., P ozzi E. Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronhitis: an Italian multicenter study / / Am. J. Med.— 1992.— Vol.92, Suppl. 4A.— P.103S— 107S.Yernault J.-C ., Russell D. Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis results of multinational studies / / Int. J. Antimicrob. Agents.— 1992.— Vol.2.— P .39— 48.Yernault J.-C ., Russell D. Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis results of multinational studies / / Int. J. Antimicrob. Agents.— 1992.— Vol.2.— P .39— 48.Saenz-Aguirre C., Amaya-Tapia G., Andrade-Villanueva J. et al. Comparison 'of the safety and efficacy of lomefloxacin and amoxicillin in the treatment of acute exacerbations of chronic bronchitis: results from a Latin—American multicenter study //Ibid .— P .49— 54.Saenz-Aguirre C., Amaya-Tapia G., Andrade-Villanueva J. et al. Comparison 'of the safety and efficacy of lomefloxacin and amoxicillin in the treatment of acute exacerbations of chronic bronchitis: results from a Latin—American multicenter study //Ibid .— P .49— 54.Gotfried M .IL , Ellison IV. T. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbation of chronic bronchitis / / Am. J. Med.— 1992.— Vol.92, Suppl. 4Л.— P 108S— 113S.Gotfried M .IL , Ellison IV. T. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbation of chronic bronchitis / / Am. J. Med.— 1992.— Vol.92, Suppl. 4Л.— P 108S— 113S.Kemper P., Kohler D. A double-blind study of two dosage regiments of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiologv / / Ibid.— P.98S— 102S.Kemper P., Kohler D. A double-blind study of two dosage regiments of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiologv / / Ibid.— P.98S— 102S.Обзор исследований по безопасности максаквина / / Пульмонология.— 1993.— Приложение 1.Обзор исследований по безопасности максаквина / / Пульмонология.— 1993.— Приложение 1.Baldwin D.R., Wise R., Andrews J.M . et al. Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration / / Br. J. Clin. Pharmacol.— 1993.— Inpress.Baldwin D.R., Wise R., Andrews J.M . et al. Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration / / Br. J. Clin. Pharmacol.— 1993.— Inpress.Baldwin D .R ., Jloneybourne D ., Andrews J.M . et a l. Concentrations of oral lomefloxacin in serum and bronchial mucosa / / Antimicrob. Agents Chemother.— 1990.— Vol.34.— P .1017— 1019.Baldwin D .R ., Jloneybourne D ., Andrews J.M . et a l. Concentrations of oral lomefloxacin in serum and bronchial mucosa / / Antimicrob. Agents Chemother.— 1990.— Vol.34.— P .1017— 1019.Loos U., Sorgel P., Muth P. et al. Pulmonary disposition of lomefloxacin / / Program and Abstracts of the Twenty-Ninth Interscience Conference on Antimicrobial Agents and Chemoterapy.— Washington: American Society for Microbiology, 1989.— P .317.— Abstract 1272.Loos U., Sorgel P., Muth P. et al. Pulmonary disposition of lomefloxacin / / Program and Abstracts of the Twenty-Ninth Interscience Conference on Antimicrobial Agents and Chemoterapy.— Washington: American Society for Microbiology, 1989.— P .317.— Abstract 1272.Nix D .E., Norm an A ., Schentag J.J. Effect of lomefloxacin on theophilline pharmacokinetics / / Antimicrob . Agents Chem other.— 1989.— Vol.33.— P .1006— 1008.Nix D .E., Norm an A ., Schentag J.J. Effect of lomefloxacin on theophilline pharmacokinetics / / Antimicrob . Agents Chem other.— 1989.— Vol.33.— P .1006— 1008.Staib A .H ., H arder S ., Ruhr U., Wack C. Interaction of quinolones with the theofilline metabolism in man: investigations with lomefloxacin and pipemidic acid / / Int. J. Clin. Pharmacol. Ther. Toxicol.— 1989.— Vol.2 7.— P.289— 293.Staib A .H ., H arder S ., Ruhr U., Wack C. Interaction of quinolones with the theofilline metabolism in man: investigations with lomefloxacin and pipemidic acid / / Int. J. Clin. Pharmacol. Ther. Toxicol.— 1989.— Vol.2 7.— P.289— 293.Kuzuya Т., Takagi K , Apichailpichean R. et al. Kinetic interaction between teophylline and a newly developed quinolone, NY -198 / / J. Pharmacobio-Dyn.— 1989.— Vol. 12.— P .405— 409.Kuzuya Т., Takagi K , Apichailpichean R. et al. Kinetic interaction between teophylline and a newly developed quinolone, NY -198 / / J. Pharmacobio-Dyn.— 1989.— Vol. 12.— P .405— 409.Robson R .A ., Begg E .J., Atkinson II.C. et al. Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theofilline / / Br. J. Clin. Pharmacol.— 1990.— Vol.29.— P.491— 493.Robson R .A ., Begg E .J., Atkinson II.C. et al. Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theofilline / / Br. J. Clin. Pharmacol.— 1990.— Vol.29.— P.491— 493.LeBelM ., Vallee P., St-Laurent M. Influence of the lomefloxacin on the pharmacokinetics of theophylline / / Antimicrob. Agents Chemother.— 1990.— Vol.34.— P. 1254— 1256.LeBelM ., Vallee P., St-Laurent M. Influence of the lomefloxacin on the pharmacokinetics of theophylline / / Antimicrob. Agents Chemother.— 1990.— Vol.34.— P. 1254— 1256.Wijnands G .J.A., Cornel J .II., Martea М ., Vree T.B. The effect of multiple-dose oral lomefloxacin on theophylline metabolism in men / / Chest.— 1990. Vol.— 98.— P .l 440— 1444.Wijnands G .J.A., Cornel J .II., Martea М ., Vree T.B. The effect of multiple-dose oral lomefloxacin on theophylline metabolism in men / / Chest.— 1990. Vol.— 98.— P .l 440— 1444.IJealy D.P., Schoenie J.R., Stotka J., Polk R.E. Lack of interaction between lomefloxacin and caffeine in normal volunteers / / Antimicrob. Agents Chemother.— 1991.— Vol.35.— P .660— 664.IJealy D.P., Schoenie J.R., Stotka J., Polk R.E. Lack of interaction between lomefloxacin and caffeine in normal volunteers / / Antimicrob. Agents Chemother.— 1991.— Vol.35.— P .660— 664.Kunka R.L., Wong Y.Y., Lyon J.L. Effect of antacid on the pharmacokinetics of lomefloxacin. Abstract PP 1267 / / Pharm. Res.— 1988.— Vol.5, Suppl.— P.S165.Kunka R.L., Wong Y.Y., Lyon J.L. Effect of antacid on the pharmacokinetics of lomefloxacin. Abstract PP 1267 / / Pharm. Res.— 1988.— Vol.5, Suppl.— P.S165.Foster T. The effect of antacid timing on lomefloxacin bioavailability / / Pharmacotherapy.— 1991.— V o l.ll.— P. 101.Foster T. The effect of antacid timing on lomefloxacin bioavailability / / Pharmacotherapy.— 1991.— V o l.ll.— P. 101.Nix D .y Schentag J. Lomefloxacin absorption kinetis when administered with ranitidine and sucralfate / / Program and Abstracts of the Twenty-N inth Interscicnce Conference on Antimicrobial Agents and Chemotherapy.— Washington: American Society for Microbiology, 1989.— P .317.— Abstract 1276.Nix D .y Schentag J. Lomefloxacin absorption kinetis when administered with ranitidine and sucralfate / / Program and Abstracts of the Twenty-N inth Interscicnce Conference on Antimicrobial Agents and Chemotherapy.— Washington: American Society for Microbiology, 1989.— P .317.— Abstract 1276.Kurcemyer J., Lim a J ., Adam s М ., Hunt T. Lomefloxacin pharmacokinetics binding to plasma proteins and the effect of food on absorption / / Program and Abstracts of the Twenty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy .— Washington : American Society for Microbiology, 1989.— P .317.— Abstract 1275.Kurcemyer J., Lim a J ., Adam s М ., Hunt T. Lomefloxacin pharmacokinetics binding to plasma proteins and the effect of food on absorption / / Program and Abstracts of the Twenty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy .— Washington : American Society for Microbiology, 1989.— P .317.— Abstract 1275.Hooper W.D., Dickinson R.G, E adie M .J. Effect of food on absorption of lomefloxacin / / Antimicrob. Agents Chemother.— 1990.— Vol.34.— P .1797— 1799.Hooper W.D., Dickinson R.G, E adie M .J. Effect of food on absorption of lomefloxacin / / Antimicrob. Agents Chemother.— 1990.— Vol.34.— P .1797— 1799.
The authors declare that there are no conflicts of interest present.